Editas Medicine (EDIT) Other Accumulated Expenses (2015 - 2023)

Editas Medicine (EDIT) has reported Other Accumulated Expenses for 9 consecutive years, with $78000.0 the latest figure, recorded in Q2 2023.

• In Q2 2023, Other Accumulated Expenses fell 97.18% year-over-year to $78000.0; the TTM figure through Jun 2023 stood at $78000.0 (down 97.18% YoY), while the FY2022 annual figure was $1.6 million, up 16.12% from the prior year.
• Other Accumulated Expenses fell to $78000.0 in Q2 2023 per EDIT's latest filing, from $109000.0 in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $4.0 million in Q2 2020 and bottomed at $78000.0 in Q2 2023.
• Historically, Other Accumulated Expenses has averaged $1.5 million across 5 years, with a median of $1.3 million in 2020.
• Annual changes were most pronounced in 2019 — Other Accumulated Expenses surged 364.5% — and 2023, when it sank 97.18%.
• Editas Medicine's Other Accumulated Expenses stood at $2.7 million in 2019, then slumped by 57.87% to $1.1 million in 2020, then increased by 24.6% to $1.4 million in 2021, then advanced by 16.12% to $1.6 million in 2022, then plunged by 95.23% to $78000.0 in 2023.
• Business Quant data shows EDIT's Other Accumulated Expenses at $78000.0 in Q2 2023, $109000.0 in Q1 2023, and $1.6 million in Q4 2022.